CAMKK2 is involved in ethanol-induced hepatic steatosis, and treatment with caffeic acid, a phytochemical in coffee, increases its mRNA and protein expression, thereby reducing alcohol-mediated damage in mice (Lu et al., 2022). Here, CAMKK2 is linked to fatty liver disease.